The Innovation Lab will have a budget of $ 10 million, will be located in Rehovot Science Park and will be operational in 2021. The partners include the pharmaceutical companies Teva and Merck as well as the Biotech Fund.
3 min readThis story originally appeared at high level
When we talk about big projects for 2021, this is one of the most ambitious. Pharmaceuticals Pfizer, AstraZeneca, Merck, and Teva, combined with Biotech Fund and Amazon Web Serviceswill they build one Digital Health and Computational Biology Laboratory in Israel, reported Israeli authorities.
The Innovation authority and the Israeli Digital Ministry announced the creation of Innovation laboratory. The budget for the computer lab is 32 million shekels, which is the equivalent $ 10 million (about 200 million Mexican pesos). This amount, planned for the next five years, consists of contributions from partner companies and the Israeli fund.
The proposal of the powerful group was selected in a competition in which other projects participated. The new complex will go into operation in 2021 and is located in the Rehovot Science Park, where is that too Weizmann Institute of Sciences.
The goal of Innovation laboratory Be Support entrepreneurs and startups so that they begin Projects related to the healthcare industry. The companies that join the laboratory receive funding from the Innovation Authority and the National Digital Ministry, which give impetus to their creations.
“The rapid development of vaccines against the Covid-19 virus is due in part to the artificial intelligence of leading pharmaceutical companies such as Pfizer and Moderna. These areas are expected to gain in importance in the coming years. “said the innovation agency in a statement posted on its official website.
He Innovation laboratory It will also help entrepreneurs with the support of laboratory partners. In addition, they get access to their scientific knowledge and world experts to develop revolutionary drugs and treatments.
“The purpose of the lab is to support the creation and advancement of new startups that develop innovative computer technologies based on artificial intelligence aimed at the discovery of personalized treatments and solutions.”the statement ended.